InternationalJournal ofOncologyKnockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles
【送料無料】YASAI シャンプー750ml or ヘアパック600g 大容量タイプ(専用読本付き)通常よりも3倍容量でお得なサイズココナッツ由来最高級洗浄成分配合TAMA Yasai…
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
International Journal of Molecular Medicine BCL2‑regulated apoptotic process in myocardial ischemia‑reperfusion injury (Review)
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
The PROTAC selectively degrading Bcl-xL represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while sparing bone growth AbstractCitation styles